Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 5
Journal homepage
84
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan

Masaaki MoriDepartment of Pediatrics, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama 232-0024, JapanCorrespondence[email protected]
,
Syuji TakeiKagoshima University School of Medicine, Kagoshima, Japan
,
Tomoyuki ImagawaDepartment of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
,
Hiroyuki ImanakaKagoshima University School of Medicine, Kagoshima, Japan
,
Yasuhito NeromeKagoshima University School of Medicine, Kagoshima, Japan
,
Rumiko HiguchiDepartment of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
,
Yoshifumi KawanoKagoshima University School of Medicine, Kagoshima, Japan
,
Shumpei YokotaDepartment of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan
,
Noriko SugiyamaPfizer Inc., Tokyo, Japan
,
Hirotoshi YuasaPfizer Inc., Tokyo, Japan
,
Tracey FletcherPfizer Inc., Collegeville, PA, USA
&
Joseph S. WajdulaPfizer Inc., Collegeville, PA, USA
 show all
Pages 720-726 | Received 15 Aug 2011, Accepted 07 Dec 2011, Published online: 02 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tomohiro Kubota, Syuji Takei, Masaki Shimizu, Junko Yasumura, Yasuo Nakagishi, Toshitaka Kizawa, Masato Yashiro, Hiroyuki Wakiguchi, Yuichi Yamasaki & Yoshifumi Kawano. (2018) Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. Modern Rheumatology 28:5, pages 826-831.
Read now
Masaaki Mori, Naonobu Sugiyama, Yosuke Morishima, Noriko Sugiyama, Takeshi Kokubo, Syuji Takei & Shumpei Yokota. (2018) Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance. Modern Rheumatology 28:1, pages 101-107.
Read now
Tomohiro Kubota, Hiroyuki Imanaka, Syuji Takei, Tsuyoshi Yamatou, Yasuhito Nerome, Yuuichi Yamasaki, Yukiko Nonaka, Harumi Akaike, Tomoko Takezaki & Yosihumi Kawano. (2016) Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis. Modern Rheumatology 26:3, pages 358-361.
Read now
Giuseppe Murdaca, Francesca Spanò, Miriam Contatore, Andrea Guastalla, Ottavia Magnani & Francesco Puppo. (2014) Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety 13:5, pages 649-661.
Read now

Articles from other publishers (6)

Vildan Güngörer, Elif Çelikel, Zahide Ekici Tekin, Merve Cansu Polat, Nimet Öner, Tuba Kurt, Melike Mehveş Kaplan, Müge Sezer, Nilüfer Tekgöz, Cüneyt Karagöl, Serkan Coşkun & Banu Çelikel Acar. (2023) Biological Agent Switching in Patients With Juvenile Idiopathic Arthritis. JCR: Journal of Clinical Rheumatology Publish Ahead of Print.
Crossref
Martijn J H Doeleman, Erik M van Maarseveen & Joost F Swart. (2019) Immunogenicity of biologic agents in juvenile idiopathic arthritis: a systematic review and meta-analysis. Rheumatology 58:10, pages 1839-1849.
Crossref
Jeong Yun Choi, Jee Eun Chung, Ji Hyun Park, Yoon Sook Cho, Yong Woo Jung & Soo An Choi. (2018) Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study. PLOS ONE 13:11, pages e0204573.
Crossref
Heather M. Walters, Nancy Pan, Thomas J. A. Lehman, Alexa Adams, Wei-Ti Huang, Lemonia Sitaras, Susanna Cunningham-Rundles, Thomas J. Walsh & Sima S. Toussi. (2014) A prospective study comparing infection risk and disease activity in children with juvenile idiopathic arthritis treated with and without tumor necrosis factor-alpha inhibitors. Clinical Rheumatology 34:3, pages 457-464.
Crossref
Lesley J. Scott. (2014) Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases. Drugs 74:12, pages 1379-1410.
Crossref
Martina Kirchner, Leo Strothmann, Anja Sonnenschein & Wilma Mannhardt-Laakmann. (2014) Distinct Cytokine Profiles in Patients with Oligoarticular Juvenile Idiopathic Arthritis after <i>in</i> <i>Vitro</i> Blockade of Interleukin (IL)-1 and Tumor Necrosis Factor (TNF)-α. World Journal of Vaccines 04:03, pages 110-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.